### **Overview** Aarti Industries Limited (AIL) is a globally recognized, integrated specialty chemicals company headquartered in India. Founded in 1984 by first-generation technocrats, AIL has grown into a top-tier global supplier, ranking among the **top 1–4 producers globally for 75% of its product portfolio**. The company serves over **1,100 customers across 60+ countries**, including major markets in the USA, Europe, Japan, and China, and is positioned as a **"Partner of Choice"** for leading global innovators in chemicals, agrochemicals, pharmaceuticals, and advanced materials. --- ### **Core Competencies** - **Integrated Value Chains**: Full backward integration across **benzene, toluene, and sulphuric acid** enables cost optimization, supply chain resilience, and co-product utilization. - **World-Leading Process Expertise**: Among the **top 3 globally in chlorination and nitration**, and **top 2 in hydrogenation**, with proprietary technologies including: - Photochlorination - Halex (fluorination) - Balz-Schiemann reaction - Vapour-phase chemistry - Flow chemistry - Grignard reactions - **Sustainable & Circular Manufacturing**: - All 16 manufacturing facilities adhere to **zero-liquid-discharge (ZLD)** standards. - Waste-to-value initiatives include **pyrolysis of end-of-life plastics**, **HCO recovery**, and **100% export-grade calcium chloride granules from dilute HCl**. - Renewable energy initiatives (solar, hybrid power) enhance energy efficiency. --- ### **Strategic Growth Pillars (FY25–FY27)** 1. **Strengthening Core Business** - Expansion of key capacity chains: **NCB, DCB, PDA, MMA, ethylation, NT**, and **acid revamps**. - Debottlenecking and brownfield expansions to improve asset utilization. - Targeting **85–90% utilization in core product lines** by mid-2026. 2. **Expanding via Partnerships & Joint Ventures** - **Augene Chemical Pvt Ltd (50:50 JV with UPL)**: - Focus: Production of downstream amine derivatives for **agrochemicals and paints**. - Commissioning: **H1 2026** - Target: Peak revenues of **₹400–500 crore/year** within 2–3 years. - **Re Aarti Pvt Ltd (49:51 JV with ReSRL)**: - Focus: **Chemical recycling of plastics** to produce **Advanced Circular Materials (ACM)**. - Target: **500 TPD recovery capacity by 2030**; pilot plant in **Hyderabad on track**. 3. **Driving Innovation & Diversification** - **Zone IV Project** (Jhagadia, Gujarat): - A greenfield, multipurpose facility under phased commissioning (starting **H2 FY26**). - Includes a **pilot plant**, **continuous processing units**, and **automated distillation**. - Focused on **chlorotoluene derivative value chain** with 40+ high-value products for **pharma, agrochemicals, and dyes**. - EBITDA margin potential: **25–30%**. - Target **sunrise sectors**: - Battery chemicals - Electronic & semiconductor chemicals - Defense - Coatings - Carbon capture & storage - Green hydrogen & sustainable aviation fuel (SAF) from waste cooking oil. --- ### **Business Model & Segments** - **Specialty Chemicals (70–85% of revenue)**: - Key product chains: NCB, DCB, PDA, NT, nitrofluoro aromatics, chloroanilines. - High-margin products used in agrochemicals, polymers, dyes, fuel additives, and FMCG. - Over **100 products manufactured across 16 advanced facilities** in Gujarat and Maharashtra. - **CDMO Model (Contract Development & Manufacturing Organization)**: - Serves global clients in pharma, agrochemicals, and electronics. - Offers **custom synthesis**, **pilot-to-commercial scale-up**, and **IP-protected molecule development**. - **Pharmaceuticals (8–10% of revenue)**: - Demerged in 2022 to sharpen focus on chemicals; retained CDMO-style capabilities. - Serves regulated markets (USA, EU, Japan) with products like **PNCB, MDCB**, and **fluorinated intermediates**. - Focus on **niche APIs**, intermediates, and **xanthine derivatives** (e.g., caffeine, theophylline). --- ### **Innovation and R&D Ecosystem** - **Two state-of-the-art R&D centers** (Vapi & Navi Mumbai; 40,000 sq. ft.), with **DSIR-recognized labs**. - **250+ scientists and engineers**, including **19 PhDs**. - Strong IP portfolio: Over **15 patents filed** in recent years. - AI and digital-driven R&D: - **AI-powered route prediction** for complex molecules. - **Electronic lab notebooks** (ELN), **IoT**, and **real-time analytics**. - Part of **Project UNNATI 2.0** – a cloud-first, API-driven digital transformation. - Focus on **sustainable chemistries**, green solvents, process intensification, and **circular economy solutions**. --- ### **Recent & Upcoming Capacity Investments** | **Project** | **Capacity / Focus** | **Timeline** | **CAPEX (₹)** | |------------------------------------|-----------------------------------------------|------------------------|------------------------| | Zone IV Multipurpose Plant (MPP) | Chlorotoluene, advanced chemistries | Phased H2 FY26 onward | ₹2,500–3,000 crore | | Re Aarti JV (Plastic Recycling) | 500 TPD by 2030; pilot plant in Hyderabad | H1 FY26 (commissioning)| ~₹1,000 crore+ | | Augene Chemical (with UPL) | Downstream amine derivatives | H1 CY2026 | ₹300 crore (₹150 each) | | MMA Expansion | Ramped to ~260 KTPA | Completed FY25 | Integrated | | Ethylation & NT Debottlenecking | 3x ethylation; ~50% NT expansion | H1 FY25 completed | ₹600–700 crore | | Acid Revamp & NCB Expansion | Brownfield capacity upgrades | Phased FY24–FY25 | Part of broader capex | - **Total FY25 CAPEX**: **₹1,372 crore** - **Future Investment Outlook (FY25–27)**: ₹3,500–4,000 crore cumulative --- ### **Commercial Performance & Contracts** - Secured multiple long-term contracts: - **₹6,000 crore, 4-year contract** for a niche specialty chemical (2024) – volumes **doubled in CY25**. - **₹3,000 crore, 9-year contract** for a global agrochemical intermediate. - Multi-year deals with **UPL, DFPCL**, and others for **critical raw material supply**. - Pricing Mechanism: - Predominantly **cost-plus pricing** to protect margins from input volatility. - **Hedging** for forex exposure (3–36 months), with **~48% of revenues in USD**. --- ### **Global Positioning & Market Trends** - **China+1 Enabler**: Positioned as a **low-cost, sustainable, high-quality alternative to Chinese manufacturers**, particularly in complex chemistry. - Targeting **bifurcated China vs. non-China** supply chains in polymers and agrochemicals. - Active participant in global **de-risking of chemical value chains**, offering **end-to-end India-based manufacturing**. - Exports account for **~52%** of revenue, with strong traction in **USA, Europe, Middle East, and APAC**. --- ### **Sustainability & Compliance** - **Zero-Liquid-Discharge** in all manufacturing units. - **REACH, USFDA, ISCC-PLUS, ISO 27001:2022, NABL (ISO 17025)** certified. - Waste gas utilization (e.g., **HCl-to-CSA**, **HCO-to-energy**), **low LTIFR (0.15)**. - Investment in renewable energy: **13.2 MW hybrid plant**, **solar PPA**, on track for net-zero milestones. --- ### **Leadership & Governance** - **CEO**: **Suyog Kotecha** (joined Jul 2024), former leader at **Reliance Industries & McKinsey**, bringing global-scale operational and strategic expertise. - Focused on **Project UNNATI** for digital and operational agility. - Corporate structure optimized post-pharma demerger for lean, chemicals-focused growth.